Press release

Phillips-Medisize Expands FDA Compliant Medical Manufacturing Capacity to Support Growing Customer Needs

Sponsored by Businesswire

a Molex company
, today announces the Little Rock, Arkansas facility
is fully compliant with the Current Good Manufacturing Practice (CGMP)
regulations enforced by the FDA. The facility is FDA 21 CFR part 820
compliant. As a result, this 380,000-square foot facility enhances
Phillips-Medisize’s medical manufacturing services with capabilities
around molding, stamping, plating and assembly which allows for vertical
integration of manufacturing, electronics and connected device solutions
all in one site. The facility also leverages existing dedicated white
space along with Class 8 cleanroom space for medical manufacturing.

For decades, Phillips-Medisize has been designing, developing and
manufacturing drug delivery devices. Phillips-Medisize’s current
end-to-end capabilities serve pharmaceutical, diagnostics and medical
device companies with a wide range of solutions for both mechanical and
connected devices. Customers benefit from effective quality systems,
risk management approaches and dedicated clinical build sites, as well
as the ability to produce drug delivery devices and combination
products, including electronic PCBA manufacturing at facilities around
the globe.

“We believe most drug delivery devices will benefit from being part of a
connected health system. For that reason, we diligently pursue
opportunities for lowering the cost of adding connectivity modules to
drug delivery devices,” said Matt Jennings, CEO and President of
Phillips-Medisize. As a new FDA compliant manufacturing site, the Little
Rock facility combines the innovative solutions and knowledge of Molex’s
existing electronics production operations with Phillips-Medisize’s
proven platform of drug delivery and medical device expertise.

About Phillips-Medisize:

Phillips-Medisize, a Molex company, is an end-to-end provider of
innovation, development and manufacturing solutions to the
pharmaceutical, diagnostics, medical device and specialty commercial
market segments. Backed by the combined global resources of Molex and
its parent company Koch Industries, Phillips-Medisize’s core advantage
is the knowledge of its people to integrate design, molding,
electronics, and automation, providing innovative, high-quality
manufacturing solutions. For more information, please visit